• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-36受体拮抗剂基因:对其在儿童脓疱型银屑病发病机制及治疗中作用的关键见解

IL-36RN gene: key insights into its role in pediatric pustular psoriasis pathogenesis and treatment.

作者信息

Wang Ye, Li Mingyue, Hou Changcheng, Wang Yueyue, Guo Jing, Wang Xurui

机构信息

School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

Health Care Department, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.

出版信息

Front Pediatr. 2025 Mar 19;13:1520804. doi: 10.3389/fped.2025.1520804. eCollection 2025.

DOI:10.3389/fped.2025.1520804
PMID:40176872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11964088/
Abstract

Pediatric pustular psoriasis (PPP) is an autoimmune skin disease that seriously affects the physical and mental health of children. The IL-36RN (Interleukin-36 Receptor Antagonist) gene plays a key role in the pathogenesis of PPP. This review comprehensively elaborates on the research progress of IL-36RN in the context of the pathogenesis and treatment of PPP, covering the basic structure, function, mutation sites and types, and inheritance patterns of the gene and its role in the pathogenesis of PPP. In addition, we discussed the frequency of IL-36RN mutations in patients with different types of PPP and the treatment methods for these patients, aiming to provide a valuable reference for further research and treatment of this disease.

摘要

儿童脓疱型银屑病(PPP)是一种严重影响儿童身心健康的自身免疫性皮肤病。白细胞介素-36受体拮抗剂(IL-36RN)基因在PPP的发病机制中起关键作用。本综述全面阐述了IL-36RN在PPP发病机制和治疗方面的研究进展,涵盖了该基因的基本结构、功能、突变位点和类型、遗传模式及其在PPP发病机制中的作用。此外,我们还讨论了不同类型PPP患者中IL-36RN突变的频率以及这些患者的治疗方法,旨在为该疾病的进一步研究和治疗提供有价值的参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d529/11964088/19ffe0bb7f67/fped-13-1520804-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d529/11964088/19ffe0bb7f67/fped-13-1520804-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d529/11964088/19ffe0bb7f67/fped-13-1520804-g001.jpg

相似文献

1
IL-36RN gene: key insights into its role in pediatric pustular psoriasis pathogenesis and treatment.白细胞介素-36受体拮抗剂基因:对其在儿童脓疱型银屑病发病机制及治疗中作用的关键见解
Front Pediatr. 2025 Mar 19;13:1520804. doi: 10.3389/fped.2025.1520804. eCollection 2025.
2
Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.脓疱型银屑病:病理生理学与治疗选择最新进展的叙述性综述
Dermatol Ther (Heidelb). 2021 Dec;11(6):1917-1929. doi: 10.1007/s13555-021-00612-x. Epub 2021 Oct 9.
3
Integrative genomic analysis of interleukin-36RN and its prognostic value in cancer.白细胞介素-36RN的综合基因组分析及其在癌症中的预后价值
Mol Med Rep. 2016 Feb;13(2):1404-12. doi: 10.3892/mmr.2015.4667. Epub 2015 Dec 9.
4
Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis.脓疱型银屑病:全身性脓疱型银屑病中 spesolimab 的分子途径和作用。
J Allergy Clin Immunol. 2022 Apr;149(4):1402-1412. doi: 10.1016/j.jaci.2021.09.035. Epub 2021 Oct 20.
5
Generalized pustular psoriasis with a novel mutation of interleukin-36 receptor antagonist, responding to methotrexate.伴有白细胞介素-36受体拮抗剂新突变的泛发性脓疱型银屑病,对甲氨蝶呤有反应。
JAAD Case Rep. 2015 Feb 5;1(2):51-3. doi: 10.1016/j.jdcr.2014.12.007. eCollection 2015 Mar.
6
A Case of Old Age-Onset Generalized Pustular Psoriasis with a Deficiency of IL-36RN (DITRA) Treated by Granulocyte and Monocyte Apheresis.1例老年起病的泛发性脓疱型银屑病伴白细胞介素-36受体拮抗剂缺乏症(DITRA)经粒细胞和单核细胞分离术治疗的病例
Case Rep Dermatol. 2015 Feb 21;7(1):29-35. doi: 10.1159/000380876. eCollection 2015 Jan-Apr.
7
Pneumocystis jirovecii pneumonia in a patient with pustular psoriasis with an IL-36RN deficiency treated with infliximab: Case report and review of the literature.1例脓疱型银屑病合并IL-36RN缺陷患者接受英夫利昔单抗治疗后发生耶氏肺孢子菌肺炎:病例报告及文献复习
Australas J Dermatol. 2017 May;58(2):e44-e47. doi: 10.1111/ajd.12489. Epub 2016 May 12.
8
Case report: Infantile generalized pustular psoriasis with IL36RN and CARD14 gene mutations.病例报告:伴有IL36RN和CARD14基因突变的婴儿泛发性脓疱型银屑病
Front Genet. 2023 Jan 10;13:1035037. doi: 10.3389/fgene.2022.1035037. eCollection 2022.
9
Acrodermatitis continua of Hallopeau and generalised pustular psoriasis: Should they be the same or different entities? Hallopeau 连续性肢端皮炎与泛发性脓疱型银屑病:二者是否为同一疾病实体?
Exp Dermatol. 2023 Aug;32(8):1235-1245. doi: 10.1111/exd.14805. Epub 2023 Apr 14.
10
Interleukin-36 receptor antagonist alleviates airway inflammation in asthma via inhibiting the activation of Interleukin-36 pathway.白细胞介素-36 受体拮抗剂通过抑制白细胞介素-36 通路的激活缓解哮喘中的气道炎症。
Int Immunopharmacol. 2020 Apr;81:106200. doi: 10.1016/j.intimp.2020.106200. Epub 2020 Feb 7.

本文引用的文献

1
Successful Treatment of Pediatric Generalized Pustular Psoriasis (GPP) with Spesolimab: 5 Case Reports and Evaluations of Circulating IL-36 Levels.司库奇尤单抗成功治疗儿童泛发性脓疱型银屑病(GPP):5例病例报告及循环IL-36水平评估
J Inflamm Res. 2024 Nov 4;17:8199-8206. doi: 10.2147/JIR.S485077. eCollection 2024.
2
Clinical efficacy and safety of secukinumab in the treatment of generalized pustular psoriasis in the pediatric population: a systematic review of the literature.司库奇尤单抗治疗儿童泛发性脓疱型银屑病的临床疗效与安全性:文献系统评价
Front Med (Lausanne). 2024 Aug 9;11:1377381. doi: 10.3389/fmed.2024.1377381. eCollection 2024.
3
Spesolimab: A Review of the First IL-36 Blocker Approved for Generalized Pustular Psoriasis.
斯佩索利单抗:首款获批用于泛发性脓疱型银屑病的白细胞介素-36阻滞剂综述
Ann Pharmacother. 2025 Feb;59(2):174-183. doi: 10.1177/10600280241252688. Epub 2024 May 16.
4
Targeted review of mutations in patients with generalised pustular psoriasis.泛发性脓疱型银屑病患者突变的针对性综述。
Skin Health Dis. 2024 Mar 6;4(2):e343. doi: 10.1002/ski2.343. eCollection 2024 Apr.
5
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open-label, phase 3 trial.德卡伐替尼,一种口服、选择性、变构酪氨酸激酶2抑制剂,用于日本中重度斑块状、红皮病型或泛发性脓疱型银屑病患者:一项开放标签3期试验的疗效和安全性结果。
J Dermatol. 2024 Mar;51(3):365-379. doi: 10.1111/1346-8138.17074. Epub 2024 Jan 24.
6
Efficacy and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Subgroup Analysis of Chinese Patients in the Effisayil 1 Trial.司库奇尤单抗治疗泛发性脓疱型银屑病患者的疗效和安全性:Effisayil 1试验中中国患者的亚组分析
Dermatol Ther (Heidelb). 2023 Dec;13(12):3097-3110. doi: 10.1007/s13555-023-01037-4. Epub 2023 Oct 16.
7
Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial.皮下注射 spesolimab 预防泛发性脓疱型银屑病发作的疗效和安全性(Effisayil 2):一项国际、多中心、随机、安慰剂对照试验。
Lancet. 2023 Oct 28;402(10412):1541-1551. doi: 10.1016/S0140-6736(23)01378-8. Epub 2023 Sep 19.
8
Serine deficiency exacerbates psoriatic skin inflammation by regulating S-adenosyl methionine-dependent DNA methylation and NF-κB signalling activation in keratinocytes.丝氨酸缺乏通过调节角质形成细胞中 S-腺苷甲硫氨酸依赖的 DNA 甲基化和 NF-κB 信号激活来加重银屑病皮肤炎症。
J Eur Acad Dermatol Venereol. 2024 Jan;38(1):145-156. doi: 10.1111/jdv.19492. Epub 2023 Sep 15.
9
Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease.白细胞介素(IL)-33、IL-36和IL-38在炎症性肠病中的促炎和抗炎作用
J Gastroenterol. 2023 Feb;58(2):69-78. doi: 10.1007/s00535-022-01936-x. Epub 2022 Nov 14.
10
Generalized pustular psoriasis recurring during pregnancy and lactation successfully treated with ixekizumab.妊娠和哺乳期复发的泛发性脓疱型银屑病经司库奇尤单抗成功治疗。
Dermatol Ther. 2022 Dec;35(12):e15878. doi: 10.1111/dth.15878. Epub 2022 Oct 14.